Truax Patient Services was founded in 2012 after two close friends found themselves discussing business opportunities while ice fishing in a Minnesota ice house. What began as a casual conversation quickly revealed a clear gap in the pharmaceutical space—the need for a cost-effective, efficiently run Patient Assistance Program (PAP) model. Founder and pharmacist Brian Truax carried that idea forward, leading the early development of the company by securing licensure in all 50 states and completing the required Pharmacist-in-Charge (PIC) licensing. In 2013, recognizing both the scale of the opportunity and the operational demands ahead, Brian brought on his son, Tyler Truax, to help lead day-to-day operations. Together, they built the company from the ground up—initially operating PAP programs and Naloxone kit distribution out of the basement of a RE/MAX building.

As Truax Patient Services established itself in the industry, growth followed quickly. The company hired its first pharmacy technician in 2016, followed shortly by its first pharmacist, and continued expanding through consistent business development. In 2017, Truax’s vision evolved beyond traditional PAP and Naloxone distribution into a direct-to-patient cash model designed to eliminate middlemen and reduce unnecessary costs while increasing access to those facing insurance barriers. In 2018, Truax moved into its current 7,000-square-foot facility, complete with a full call center, warehousing, fill station, and administrative offices. What began as a two-person operation has grown into a dedicated team—still driven by the same mission: to streamline operations, maximize savings, and keep the patient experience front and center.